Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Biliary Tract Cancer”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableTemporarily pausedNCT06375967
What this trial is testing

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Who this might be right for
Malignant Biliary ObstructionBiliary Tract NeoplasmsPancreatic Cancer Non-resectable
Hospital Universitari de Bellvitge 128
Testing effectiveness (Phase 2)WithdrawnNCT00487851
What this trial is testing

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract NeoplasmsDuodenal Neoplasms
Karolinska Institutet
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06569225
What this trial is testing

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Who this might be right for
Cholangiocarcinoma Resectable
University Health Network, Toronto 40
Large-scale testing (Phase 3)Looking for participantsNCT06712420
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Who this might be right for
Gall Bladder Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 114
Testing effectiveness (Phase 2)Ended earlyNCT00023946
What this trial is testing

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
National Cancer Institute (NCI) 50
Not applicableUnknownNCT02958059
What this trial is testing

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Who this might be right for
Biliary Obstructive Disease Such as CholedocholithiasisBenign Biliary StricturePeri-ampullary Cancer+2 more
Yonsei University 400
Not applicableLooking for participantsNCT06731998
What this trial is testing

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Who this might be right for
Oncologic SurgeryCancerCancer Surgery+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 48
Not applicableStudy completedNCT04596865
What this trial is testing

Recurrence After Whipple's (RAW) Study

Who this might be right for
Pancreatic CancerAmpullary CancerBile Duct Cancer+11 more
University Hospital Plymouth NHS Trust 1,484
Post-approval studies (Phase 4)Ended earlyNCT01887041
What this trial is testing

Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer

Who this might be right for
Local Tumor SpreadAdvanced CancerMetastasized+2 more
Universitätsklinikum Hamburg-Eppendorf 24
Not applicableStudy completedNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Testing effectiveness (Phase 2)UnknownNCT03603834
What this trial is testing

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Khon Kaen University 25
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Ended earlyNCT04727541
What this trial is testing

Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
AIO-Studien-gGmbH 3
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599995
What this trial is testing

Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies

Who this might be right for
Biliary Tract Cancer
Sir Run Run Shaw Hospital 34
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Looking for participantsNCT06280508
What this trial is testing

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Next Page